PATENT CLAIM ANALYSIS

Application Number: 16028024
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "480000"]

Abstract:
The present invention provides a novel method, composition, and kit for treating neuroblastoma by way of the use of a BTK inhibitor. Also provided is a method for identifying a BTK inhibitor.

Claim (Index 12):
A method for identifying a BTK inhibitor, comprising the steps of:\n (a) contacting a cell expressing both BTK and ALK with a candidate compound; (b) determining BTK-ALK association level in the cell in step (a); (c) comparing the BTK-ALK associate level obtained in step (b) with a control BTK-ALK association level in a control cell, which is identical to the cell in step (a) but has not been contacted with the candidate compound, and (d) identifying the candidate compound as a BTK inhibitor, when the BTK-ALK associate level obtained in step (b) is lower than the control BTK-ALK association level.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14131183', '14597786', '15112968', '14117898', '15900201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641640754133558
- 35 USC 102 Novelty (BERT): 0.5226923826246137
- Combined Prediction Score: 0.7400169061344816
- Mean Citation Score: 292.078884
- Max Citation Score: 301.78088
- Similarity Product: 171.52869831415174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test